Xact Kapitalforvaltning’s Kyntra Bio KYNB Stock Holding History

Xact Kapitalforvaltning’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$451K	Hold	520	–	–	0.01%	812
2019 Q4	$557K	Hold	520	–	–	0.01%	905
2019 Q3	$480K	Hold	520	–	–	0.01%	925
2019 Q2	$587K	Hold	520	–	–	0.01%	828
2019 Q1	$706K	Hold	520	–	–	0.02%	717
2018 Q4	$601K	Buy	520 +32	+7%	+$36K	0.02%	763
2018 Q3	$740K	Buy	488 +28	+6%	+$43.1K	0.02%	718
2018 Q2	$719K	Buy	460 +68	+17%	+$88.6K	0.02%	720
2018 Q1	$452K	Buy	392 +100	+34%	+$132K	0.01%	899
2017 Q4	$345K	Buy	+292	New	+$366K	0.01%	853

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Xact Kapitalforvaltning's KYNB Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Kyntra Bio (KYNB) position steady in Q1 2020 at 520 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #812.

Xact Kapitalforvaltning first reported a position in KYNB in Q4 2017 and has held it in 10 quarters since. The position peaked at $740K in Q3 2018. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

Xact Kapitalforvaltning held 520 shares of Kyntra Bio worth $451K as of Q1 2020.
Xact Kapitalforvaltning left its Kyntra Bio share count unchanged in Q1 2020.
Kyntra Bio made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #812 holding.
Xact Kapitalforvaltning first reported a position in Kyntra Bio in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Kyntra Bio position peaked at $740K in Q3 2018.
187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.